Molecular switch mediates the glucocorticoid receptor transition from tumor suppressor to oncogene in the prostate
This study identifies p63 as a critical molecular switch that maintains the glucocorticoid receptor's tumor-suppressive function in prostate cancer, revealing that its loss reprograms the receptor into an oncogene via GATA2 and FRA1-mediated transcriptional changes, thereby driving antiandrogen resistance and disease progression.